Sentences with phrase «placebo patients also»

Not exact matches

Researchers report that the only substantial difference in safety outcomes between the placebo and bococizumab groups was injection site reactions, which is also the result of the immunologic response in some patients.

The field is also expanding into patient - centered outcomes research, so not just comparing drug A with a placebo, but drug A versus drug B.» In spite of the uncertainties, she says, «It's an exciting time because we have a lot to learn.»

The placebo effect, also known as non-specific effects and the subject - expectancy effect, is the phenomenon that a patient's symptoms can be alleviated by an otherwise ineffective treatment, since the individual expects or believes that it will work.

This was the case in the new study, published in the journal Archives of General Psychiatry — patients with major depressive disorder who were given a placebo saw their symptoms improve about three quarters as much as those given paroxetine, an antidepressant also known as Paxil.

Fred Hayden of the University of Virginia at Charlottesville says both Tamiflu and placebo patients in the randomised controlled trials were also on paracetamol (acetaminophen), so the two were indeed compared.

Patients with cirrhosis were enrolled in 2 cohorts: HCV treatment - naive or HCV treatment - experienced; patients within each cohort were also stratified according to HCV genotype 1 subtype (1a or 1b) and randomly assigned to receive weight - based ribavirin (1,000 - 1,200 mg / d) or matching Patients with cirrhosis were enrolled in 2 cohorts: HCV treatment - naive or HCV treatment - experienced; patients within each cohort were also stratified according to HCV genotype 1 subtype (1a or 1b) and randomly assigned to receive weight - based ribavirin (1,000 - 1,200 mg / d) or matching patients within each cohort were also stratified according to HCV genotype 1 subtype (1a or 1b) and randomly assigned to receive weight - based ribavirin (1,000 - 1,200 mg / d) or matching placebo.

TRINOVA - 2 is evaluating pegylated liposomal doxorubicin in combination with either placebo or trebananib in previously treated patients with ovarian cancer while TRINOVA - 3, also known as ENGOT - Ov2 and Gynecologic Oncology Group — 3001, is studying the use of trebananib in front - line treatment adding it to carboplatin / paclitaxel.

The analysis, which comprised a total of 3 344 patients, shows that the two studied drugs are clearly superior to placebo with respect to antidepressant efficacy also in patients who have not experienced any side effects.

We got permission to continue following the patients in this study and we also recruited a second cohort of patients to try to run a series of placebo controlled studies.

The patients used each treatment (candesartan, propranolol or placebo) for 12 weeks, and also underwent four weeks before start and between the treatment periods without any medication at all.

Investigators took blood samples from 67 patients, ages 12 to 45 years, who also underwent a food challenge with a placebo or with peanut, tree nut, fish, shellfish, or sesame.

New research shows placebos can also benefit patients who do not have faith in them

Dr. Mehta, who chairs the RTOG's brain tumor committee, says researchers also found an increase in symptoms among patients who took bevacizumab, compared to a placebo.

In melanoma patients who are also treated with the immune therapy pembrolizumab after surgery, the risk of recurrence of the disease is almost twice as small as in patients who receive a placebo.

We also performed subgroup meta - analyses by type of prevention (primary v secondary: in this study, trials involving healthy populations or patients with any specific disease except for cardiovascular disease were classified as primary prevention trials, and trials involving patients with cardiovascular disease were classified as secondary prevention trials), type of supplement by quality and dose (each supplement, vitamins only, antioxidants only, or antioxidants excluding vitamins), type of outcome (cardiovascular death, angina, fatal or non-fatal myocardial infarction, stroke, or transient ischaemic attack), type of outcome in each supplement, type of study design (randomised, double blind, placebo controlled trial v open label, randomised controlled trial), methodological quality (high v low), duration of treatment (< 5 years v ≥ 5 years), funding source (pharmaceutical industry v independent organisation), provider of supplements (pharmaceutical industry v not pharmaceutical industry), type of control (placebo v no placebo), number of participants (≥ 10000 v < 10000), and supplements given singly or in combination with other vitamin or antioxidant supplements by quality.

In separate studies, patients who took either Requip or Mirapex were more likely to feel improvement over a 12 - week period than those who took placebos; both drugs have also been shown to be safe and effective for up to nine months.

Zoloft (sertraline) and Remeron (mirtazapine), which are both available as generics, also generated more — and more severe — side effects than placebo, leading the researchers to suggest that these and other antidepressants should be reserved for dementia patients whose depression fails to respond to more conservative treatments, such as psychotherapy.

However, researchers also found that Vytorin - treated patients seemed to have a greater risk of getting certain cancers — such as prostate, gastrointestinal, and skin — than those treated with a placebo.